Sort
46,585 grants matching “heart failure”
Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury
$663,812Pal Pacher · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2009 · AA
Role of midlife cardiovascular disease on Alzheimerâs Pathology and cerebrovascular reactivity in the young-old.
$663,774Ann D. Cohen · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · AG
MRI cardiovascular catheterization technology development
$663,768Robert J Lederman · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Change of Institution
$663,750Caroline E Burns · Boston Children'S Hospital · R35 · FY2023 · HL
Change of Institution
$663,750Caroline E Burns · Boston Children'S Hospital · R35 · FY2020 · HL
Change of Institution
$663,750Caroline E Burns · Boston Children'S Hospital · R35 · FY2021 · HL
Change of Institution
$663,750Caroline E Burns · Boston Children'S Hospital · R35 · FY2022 · HL
Genetically-engineered pig orthotopic (life-supporting) heart transplantation (OHTx) in baboons: establishing consistent graft survival and overcoming rapid post-Tx organ growth
$663,749Muhammad M Mohiuddin · Massachusetts General Hospital · U19 · FY2024 · AI
Regulation of disease progression by ER stress
$663,730A Brent Carter · University Of Alabama At Birmingham · R01 · FY2025 · HL
Angiotensin II Receptors And Signaling Mechanisms
$663,660Kevin J Catt · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD
A Rational Engineering Design Approach to Minimizing the Off-Target Effects of Baroreceptor Activation Therapy
$663,655Kip A Ludwig · University Of Wisconsin-Madison · R01 · FY2022 · EB
Minimally Invasive Pediatric VAD for Treatment of Acute Heart Failure
$663,647Scott C Corbett · Abiomed, Inc. · R44 · FY2011 · HL
Inflammatory and Genetic Cardiomyopathies: Metabolic Phenotyping to Guide Diagnosis and Therapy
$663,578Babak Nazer · University Of Washington · R01 · FY2025 · HL
IGF::OT::IGF Coronary Artery Risk Development in Young Adults (CARDIA) Study -
$663,397Donald Lloyd-Jones · Northwestern University At Chicago · N01 · FY2014 · HL
Developing Oral LT3 Therapy for Heart Failure
$663,317Anne R Cappola · University Of Pennsylvania · R33 · FY2022 · HL
A Role of PKG1a and Inhibitors of cGMP Phosphodiesterase in Post MI VT in Mouse Models for Type II Diabetes and Metabolic Syndrome
$663,296Jonas Bernard Galper · Tufts Medical Center · R01 · FY2020 · HL
Adverse pregnancy outcomes and long-term risk of cardiovascular disease in women
$663,271Casey Crump · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · HL
Development of a Percutaneous Double Lumen Cannula-Based Cavopulmonary Assist System Toward Clinical Application
$663,225Dongfang Wang · University Of Kentucky · R01 · FY2025 · HL
Targeting cognitive function and interoceptive awareness to improve self-management in patients with co-morbid heart failure and cognitive impairment.
$663,220Elena Salmoirago-Blotcher · Miriam Hospital · R01 · FY2024 · AG
Targeting cognitive function and interoceptive awareness to improve self-management in patients with co-morbid heart failure and cognitive impairment.
$663,220Elena Salmoirago-Blotcher · Miriam Hospital · R01 · FY2023 · AG
The Cause of Systemic Inflammatory Response during Cardiopulmonary Bypass and Prevention by Nitric Oxide
$663,177Alvaro Rojas-Pena · University Of Michigan At Ann Arbor · R01 · FY2020 · HL
Ventricular Vascular Coupling: Correlates and Prognosis
$663,167Vasan S. Ramachandran · Boston University Medical Campus · R01 · FY2007 · HL
Genetic Analysis of Murine Chronic Hypoxia-Induced Pulmonary Hypertension
$663,165William C Nichols · Cincinnati Childrens Hosp Med Ctr · R01 · FY2013 · HL
Mechanistic underpinnings of increased adipose tissue in HFpEF
$663,147Flora Sam · Boston University Medical Campus · R01 · FY2022 · HL
Mechanistic underpinnings of increased adipose tissue in HFpEF
$663,147Flora Sam · Boston University Medical Campus · R01 · FY2021 · HL